Answers are grounded in this paper and cite their sources.
Chronic leukemia varies greatly in the severity of its symptoms and in the duration of life. At the present time radiotherapy is the only method of treatment which appears to have a significant effect on the clinical manifestations and course. Yet only a few statistical studies of the symptoms and signs and their relation to prognosis and life expectancy have been published. The following analysis is based on 64 patients with myeloid and 64 with lymphatic leukemia treated by x-rays at the Presbyterian Hospital in New York between the years 1919 and 1939, inclusive. Cases in which the duration of life was less than four months from onset of symptoms were classified as acute and are not included in this study. The few cases diagnosed as monocytic, basophilic, and eosinophilic leukemia were placed under the two main classifications of myeloid and lymphatic. Treatment Technic and Rationale All patients with chronic leukemia received x-ray therapy according to the technic set forth in Table I. Local application was the method employed in all but 2 cases, in which general body irradiation was given. In the early years medium voltage was used; later only high-voltage therapy was given. The factors for the latter were usually as follows: 200 kv., 8 or 25 ma., 50 cm. T.S.D., and 1.0 mm. Cu plus 1.0 mm. A1 filter. The skin over the spleen was given 25–50 r once or twice a week for several weeks, after which a dose of about 75 r was administered routinely once a week. If enlarged peripheral lymph nodes were present, they received an initial dose of 50 r at the same time, which, after one or two weeks, was elevated to 100 r weekly. The usual supportive measures, the most important of which was transfusion, were employed when indicated. The treatment was in all cases individualized, since the aim was not only to reduce the white blood count and to shrink the palpable masses but also to maintain the patient in an optimum state of well-being and efficiency for as long a period as possible. Analysis of Clinical Material Age: The average age of the patients with myeloid leukemia was 41.1 years and of those with lymphatic leukemia, 49.6 years. These figures conform quite well with the literature as a whole (1–6). Sex: More males than females have leukemia, the figures quoted in the literature varying from 60 to 80 per cent. Of our series 69, or 54 per cent, were men. The 64 myeloid cases were equally divided between males and females. Of the lymphatic group, 37 (58 per cent) were males and 27 (42 per cent) females. Initial Symptoms and Signs Weakness and loss of weight occurred about one and one-half times as frequently in the patients with myeloid leukemia as in those with lymphatic leukemia, in 70 and 66 per cent as compared with 47 and 38 per cent, respectively. About one-third of all patients, whether of the myeloid or lymphatic group, complained of fatigue.
No takes yet. Share an insight, caveat, or question.
Lucien M. Pascucci (1942) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: